[A17-57] Nonacog beta pegol (haemophilia B) – Benefit assessment according to §35a Social Code Book V
Last updated 01.02.2018
Project no.:
A17-57
Commission:
Commission awarded on 27.10.2017 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Haematology
Treatment and prophylaxis of bleeding in patients with haemophilia B who are at least 12 years of age
No relevant data; added benefit not proven
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A23-90 | Nonacog beta pegol (haemophilia B, children < 12 years) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2018-06-26 A G-BA decision was published.